nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—Alzheimer's disease	0.711	1	CbGaD
Linezolid—MAOA—locus ceruleus—Alzheimer's disease	0.013	0.424	CbGeAlD
Linezolid—MAOA—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOB—Alzheimer's disease	0.0101	0.126	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—KLK6—Alzheimer's disease	0.00594	0.074	CbGpPWpGaD
Linezolid—MAOA—Amine Oxidase reactions—MAOB—Alzheimer's disease	0.00578	0.0721	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.00328	0.0409	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—Alzheimer's disease	0.00269	0.0335	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—Alzheimer's disease	0.00234	0.0292	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—SNCA—Alzheimer's disease	0.00232	0.0289	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.00227	0.0284	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—MAOB—Alzheimer's disease	0.00225	0.0281	CbGpPWpGaD
Linezolid—MAOB—embryo—Alzheimer's disease	0.00213	0.0696	CbGeAlD
Linezolid—MAOA—Biogenic Amine Synthesis—CHAT—Alzheimer's disease	0.00209	0.0261	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—SOD1—Alzheimer's disease	0.00206	0.0257	CbGpPWpGaD
Linezolid—MAOA—Serotonin Transporter Activity—SLC6A4—Alzheimer's disease	0.00191	0.0239	CbGpPWpGaD
Linezolid—MAOB—forebrain—Alzheimer's disease	0.00188	0.0616	CbGeAlD
Linezolid—MAOA—embryo—Alzheimer's disease	0.00182	0.0594	CbGeAlD
Linezolid—MAOB—telencephalon—Alzheimer's disease	0.00173	0.0566	CbGeAlD
Linezolid—MAOA—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.00171	0.0213	CbGpPWpGaD
Linezolid—MAOA—Biogenic Amine Synthesis—ACHE—Alzheimer's disease	0.00162	0.0203	CbGpPWpGaD
Linezolid—MAOA—forebrain—Alzheimer's disease	0.00161	0.0526	CbGeAlD
Linezolid—MAOA—Neurotransmitter Release Cycle—SLC18A3—Alzheimer's disease	0.00153	0.0191	CbGpPWpGaD
Linezolid—MAOA—telencephalon—Alzheimer's disease	0.00148	0.0483	CbGeAlD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00143	0.0179	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—PTK2B—Alzheimer's disease	0.00133	0.0166	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—SOD1—Alzheimer's disease	0.00129	0.0161	CbGpPWpGaD
Linezolid—MAOB—nervous system—Alzheimer's disease	0.00102	0.0334	CbGeAlD
Linezolid—MAOB—central nervous system—Alzheimer's disease	0.000985	0.0322	CbGeAlD
Linezolid—Ecchymosis—Donepezil—Alzheimer's disease	0.00097	0.00545	CcSEcCtD
Linezolid—MAOB—cerebellum—Alzheimer's disease	0.000963	0.0315	CbGeAlD
Linezolid—MAOA—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000959	0.012	CbGpPWpGaD
Linezolid—Vaginal inflammation—Rivastigmine—Alzheimer's disease	0.000953	0.00535	CcSEcCtD
Linezolid—Sepsis—Donepezil—Alzheimer's disease	0.000931	0.00523	CcSEcCtD
Linezolid—Candida infection—Memantine—Alzheimer's disease	0.00093	0.00522	CcSEcCtD
Linezolid—MAOA—Neurotransmitter Release Cycle—CHAT—Alzheimer's disease	0.000919	0.0115	CbGpPWpGaD
Linezolid—Neuropathy—Memantine—Alzheimer's disease	0.000914	0.00514	CcSEcCtD
Linezolid—Hypokalaemia—Galantamine—Alzheimer's disease	0.000914	0.00514	CcSEcCtD
Linezolid—Candida infection—Rivastigmine—Alzheimer's disease	0.00091	0.00511	CcSEcCtD
Linezolid—Fluid retention—Rivastigmine—Alzheimer's disease	0.000905	0.00508	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.0009	0.0112	CbGpPWpGaD
Linezolid—Vaginal infection—Rivastigmine—Alzheimer's disease	0.000899	0.00505	CcSEcCtD
Linezolid—Neuropathy—Rivastigmine—Alzheimer's disease	0.000895	0.00502	CcSEcCtD
Linezolid—Gastritis—Galantamine—Alzheimer's disease	0.000889	0.00499	CcSEcCtD
Linezolid—MAOA—Melatonin metabolism and effects—CYP2D6—Alzheimer's disease	0.000881	0.011	CbGpPWpGaD
Linezolid—Urine output increased—Memantine—Alzheimer's disease	0.000881	0.00495	CcSEcCtD
Linezolid—MAOA—nervous system—Alzheimer's disease	0.000873	0.0285	CbGeAlD
Linezolid—Urine output increased—Rivastigmine—Alzheimer's disease	0.000861	0.00484	CcSEcCtD
Linezolid—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.000859	0.00482	CcSEcCtD
Linezolid—Injury—Donepezil—Alzheimer's disease	0.000847	0.00476	CcSEcCtD
Linezolid—Sepsis—Memantine—Alzheimer's disease	0.000845	0.00475	CcSEcCtD
Linezolid—MAOA—central nervous system—Alzheimer's disease	0.000841	0.0275	CbGeAlD
Linezolid—Sepsis—Rivastigmine—Alzheimer's disease	0.000827	0.00464	CcSEcCtD
Linezolid—MAOA—cerebellum—Alzheimer's disease	0.000822	0.0268	CbGeAlD
Linezolid—Phlebitis—Memantine—Alzheimer's disease	0.000821	0.00461	CcSEcCtD
Linezolid—Thirst—Donepezil—Alzheimer's disease	0.000818	0.0046	CcSEcCtD
Linezolid—Thrombophlebitis—Memantine—Alzheimer's disease	0.000817	0.00459	CcSEcCtD
Linezolid—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000807	0.00453	CcSEcCtD
Linezolid—Polyuria—Memantine—Alzheimer's disease	0.000805	0.00452	CcSEcCtD
Linezolid—Phlebitis—Rivastigmine—Alzheimer's disease	0.000803	0.00451	CcSEcCtD
Linezolid—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.000799	0.00449	CcSEcCtD
Linezolid—Hypoglycaemia—Donepezil—Alzheimer's disease	0.000798	0.00448	CcSEcCtD
Linezolid—Disorientation—Memantine—Alzheimer's disease	0.00079	0.00444	CcSEcCtD
Linezolid—Polyuria—Rivastigmine—Alzheimer's disease	0.000788	0.00442	CcSEcCtD
Linezolid—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000783	0.0044	CcSEcCtD
Linezolid—MAOB—brain—Alzheimer's disease	0.000782	0.0256	CbGeAlD
Linezolid—Hyponatraemia—Donepezil—Alzheimer's disease	0.000782	0.00439	CcSEcCtD
Linezolid—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00078	0.00438	CcSEcCtD
Linezolid—Pneumonia—Galantamine—Alzheimer's disease	0.000779	0.00437	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.000779	0.00437	CcSEcCtD
Linezolid—Injury—Memantine—Alzheimer's disease	0.000769	0.00432	CcSEcCtD
Linezolid—MAOB—Biological oxidations—CYP46A1—Alzheimer's disease	0.000762	0.0095	CbGpPWpGaD
Linezolid—Renal failure—Galantamine—Alzheimer's disease	0.000761	0.00428	CcSEcCtD
Linezolid—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000759	0.00426	CcSEcCtD
Linezolid—Injury—Rivastigmine—Alzheimer's disease	0.000752	0.00423	CcSEcCtD
Linezolid—Thirst—Rivastigmine—Alzheimer's disease	0.000727	0.00408	CcSEcCtD
Linezolid—Hypoglycaemia—Memantine—Alzheimer's disease	0.000724	0.00407	CcSEcCtD
Linezolid—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000719	0.00404	CcSEcCtD
Linezolid—Hyponatraemia—Memantine—Alzheimer's disease	0.00071	0.00399	CcSEcCtD
Linezolid—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000709	0.00398	CcSEcCtD
Linezolid—Hypokalaemia—Donepezil—Alzheimer's disease	0.000709	0.00398	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.000707	0.00397	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000701	0.00394	CcSEcCtD
Linezolid—Cramp muscle—Donepezil—Alzheimer's disease	0.000701	0.00394	CcSEcCtD
Linezolid—Haemoglobin—Galantamine—Alzheimer's disease	0.000699	0.00392	CcSEcCtD
Linezolid—MAOA—Serotonin Transporter Activity—IL1B—Alzheimer's disease	0.000695	0.00867	CbGpPWpGaD
Linezolid—Haemorrhage—Galantamine—Alzheimer's disease	0.000695	0.0039	CcSEcCtD
Linezolid—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000694	0.0039	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000692	0.00389	CcSEcCtD
Linezolid—Gastritis—Donepezil—Alzheimer's disease	0.000689	0.00387	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000687	0.00386	CcSEcCtD
Linezolid—MAOA—brain—Alzheimer's disease	0.000667	0.0218	CbGeAlD
Linezolid—Eosinophilia—Donepezil—Alzheimer's disease	0.000666	0.00374	CcSEcCtD
Linezolid—MAOA—Oxidative Stress—SOD1—Alzheimer's disease	0.000663	0.00826	CbGpPWpGaD
Linezolid—Pancreatitis—Donepezil—Alzheimer's disease	0.00066	0.00371	CcSEcCtD
Linezolid—Sweating increased—Donepezil—Alzheimer's disease	0.000656	0.00368	CcSEcCtD
Linezolid—Liver function test abnormal—Memantine—Alzheimer's disease	0.000653	0.00367	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000649	0.00809	CbGpPWpGaD
Linezolid—Tinnitus—Galantamine—Alzheimer's disease	0.000648	0.00364	CcSEcCtD
Linezolid—Hypokalaemia—Memantine—Alzheimer's disease	0.000643	0.00361	CcSEcCtD
Linezolid—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000639	0.00359	CcSEcCtD
Linezolid—MAOA—Oxidative Stress—HMOX1—Alzheimer's disease	0.000638	0.00795	CbGpPWpGaD
Linezolid—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000637	0.00358	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000636	0.00793	CbGpPWpGaD
Linezolid—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000629	0.00354	CcSEcCtD
Linezolid—Gastritis—Memantine—Alzheimer's disease	0.000626	0.00351	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000624	0.0035	CcSEcCtD
Linezolid—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000623	0.0035	CcSEcCtD
Linezolid—Gastritis—Rivastigmine—Alzheimer's disease	0.000612	0.00344	CcSEcCtD
Linezolid—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000607	0.00341	CcSEcCtD
Linezolid—Pneumonia—Donepezil—Alzheimer's disease	0.000604	0.00339	CcSEcCtD
Linezolid—Pancreatitis—Memantine—Alzheimer's disease	0.000599	0.00337	CcSEcCtD
Linezolid—MAOA—Oxidative Stress—SOD2—Alzheimer's disease	0.000596	0.00744	CbGpPWpGaD
Linezolid—Flatulence—Galantamine—Alzheimer's disease	0.000596	0.00335	CcSEcCtD
Linezolid—Sweating increased—Memantine—Alzheimer's disease	0.000595	0.00334	CcSEcCtD
Linezolid—Dysgeusia—Galantamine—Alzheimer's disease	0.000592	0.00333	CcSEcCtD
Linezolid—Renal failure—Donepezil—Alzheimer's disease	0.00059	0.00331	CcSEcCtD
Linezolid—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000586	0.00329	CcSEcCtD
Linezolid—Sweating increased—Rivastigmine—Alzheimer's disease	0.000582	0.00327	CcSEcCtD
Linezolid—Muscle spasms—Galantamine—Alzheimer's disease	0.000582	0.00327	CcSEcCtD
Linezolid—Pancytopenia—Memantine—Alzheimer's disease	0.00058	0.00326	CcSEcCtD
Linezolid—Neutropenia—Memantine—Alzheimer's disease	0.000571	0.00321	CcSEcCtD
Linezolid—Vision blurred—Galantamine—Alzheimer's disease	0.00057	0.0032	CcSEcCtD
Linezolid—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000568	0.00319	CcSEcCtD
Linezolid—Anaemia—Galantamine—Alzheimer's disease	0.000559	0.00314	CcSEcCtD
Linezolid—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000556	0.00312	CcSEcCtD
Linezolid—Hyperglycaemia—Memantine—Alzheimer's disease	0.000551	0.0031	CcSEcCtD
Linezolid—Pneumonia—Memantine—Alzheimer's disease	0.000548	0.00308	CcSEcCtD
Linezolid—Vertigo—Galantamine—Alzheimer's disease	0.000544	0.00305	CcSEcCtD
Linezolid—Haemoglobin—Donepezil—Alzheimer's disease	0.000541	0.00304	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00054	0.00303	CcSEcCtD
Linezolid—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000539	0.00303	CcSEcCtD
Linezolid—Haemorrhage—Donepezil—Alzheimer's disease	0.000539	0.00303	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000537	0.0067	CbGpPWpGaD
Linezolid—Pneumonia—Rivastigmine—Alzheimer's disease	0.000536	0.00301	CcSEcCtD
Linezolid—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000536	0.00301	CcSEcCtD
Linezolid—Renal failure—Memantine—Alzheimer's disease	0.000536	0.00301	CcSEcCtD
Linezolid—Pharyngitis—Donepezil—Alzheimer's disease	0.000535	0.003	CcSEcCtD
Linezolid—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000534	0.003	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000528	0.00297	CcSEcCtD
Linezolid—Cough—Galantamine—Alzheimer's disease	0.000528	0.00297	CcSEcCtD
Linezolid—Convulsion—Galantamine—Alzheimer's disease	0.000524	0.00294	CcSEcCtD
Linezolid—Renal failure—Rivastigmine—Alzheimer's disease	0.000524	0.00294	CcSEcCtD
Linezolid—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000522	0.00293	CcSEcCtD
Linezolid—Hypertension—Galantamine—Alzheimer's disease	0.000522	0.00293	CcSEcCtD
Linezolid—MAOA—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000504	0.00629	CbGpPWpGaD
Linezolid—Dry mouth—Galantamine—Alzheimer's disease	0.000504	0.00283	CcSEcCtD
Linezolid—MAOA—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000502	0.00626	CbGpPWpGaD
Linezolid—Tinnitus—Donepezil—Alzheimer's disease	0.000502	0.00282	CcSEcCtD
Linezolid—Haemoglobin—Memantine—Alzheimer's disease	0.000492	0.00276	CcSEcCtD
Linezolid—Haemorrhage—Memantine—Alzheimer's disease	0.000489	0.00275	CcSEcCtD
Linezolid—Hypoaesthesia—Memantine—Alzheimer's disease	0.000487	0.00273	CcSEcCtD
Linezolid—Pharyngitis—Memantine—Alzheimer's disease	0.000485	0.00273	CcSEcCtD
Linezolid—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000483	0.00272	CcSEcCtD
Linezolid—Chills—Donepezil—Alzheimer's disease	0.000483	0.00271	CcSEcCtD
Linezolid—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000481	0.0027	CcSEcCtD
Linezolid—Skin disorder—Galantamine—Alzheimer's disease	0.00048	0.00269	CcSEcCtD
Linezolid—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000478	0.00269	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP46A1—Alzheimer's disease	0.000478	0.00596	CbGpPWpGaD
Linezolid—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000477	0.00268	CcSEcCtD
Linezolid—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000476	0.00267	CcSEcCtD
Linezolid—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000475	0.00267	CcSEcCtD
Linezolid—Anorexia—Galantamine—Alzheimer's disease	0.000471	0.00264	CcSEcCtD
Linezolid—Erythema—Donepezil—Alzheimer's disease	0.000469	0.00263	CcSEcCtD
Linezolid—Erythema multiforme—Memantine—Alzheimer's disease	0.000462	0.0026	CcSEcCtD
Linezolid—Flatulence—Donepezil—Alzheimer's disease	0.000462	0.0026	CcSEcCtD
Linezolid—Dysgeusia—Donepezil—Alzheimer's disease	0.000459	0.00258	CcSEcCtD
Linezolid—Tinnitus—Memantine—Alzheimer's disease	0.000456	0.00256	CcSEcCtD
Linezolid—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000452	0.00254	CcSEcCtD
Linezolid—Muscle spasms—Donepezil—Alzheimer's disease	0.000451	0.00253	CcSEcCtD
Linezolid—Insomnia—Galantamine—Alzheimer's disease	0.000447	0.00251	CcSEcCtD
Linezolid—Tinnitus—Rivastigmine—Alzheimer's disease	0.000446	0.00251	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000445	0.00555	CbGpPWpGaD
Linezolid—Paraesthesia—Galantamine—Alzheimer's disease	0.000443	0.00249	CcSEcCtD
Linezolid—Vision blurred—Donepezil—Alzheimer's disease	0.000442	0.00248	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.00044	0.00549	CbGpPWpGaD
Linezolid—Somnolence—Galantamine—Alzheimer's disease	0.000439	0.00247	CcSEcCtD
Linezolid—Chills—Memantine—Alzheimer's disease	0.000439	0.00247	CcSEcCtD
Linezolid—MAOA—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000435	0.00543	CbGpPWpGaD
Linezolid—Dyspepsia—Galantamine—Alzheimer's disease	0.000435	0.00244	CcSEcCtD
Linezolid—Anaemia—Donepezil—Alzheimer's disease	0.000433	0.00243	CcSEcCtD
Linezolid—Chills—Rivastigmine—Alzheimer's disease	0.000429	0.00241	CcSEcCtD
Linezolid—Decreased appetite—Galantamine—Alzheimer's disease	0.000429	0.00241	CcSEcCtD
Linezolid—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000426	0.00239	CcSEcCtD
Linezolid—Fatigue—Galantamine—Alzheimer's disease	0.000426	0.00239	CcSEcCtD
Linezolid—Constipation—Galantamine—Alzheimer's disease	0.000422	0.00237	CcSEcCtD
Linezolid—Vertigo—Donepezil—Alzheimer's disease	0.000421	0.00237	CcSEcCtD
Linezolid—Flatulence—Memantine—Alzheimer's disease	0.00042	0.00236	CcSEcCtD
Linezolid—Dysgeusia—Memantine—Alzheimer's disease	0.000417	0.00234	CcSEcCtD
Linezolid—Erythema—Rivastigmine—Alzheimer's disease	0.000416	0.00234	CcSEcCtD
Linezolid—Flatulence—Rivastigmine—Alzheimer's disease	0.00041	0.00231	CcSEcCtD
Linezolid—Cough—Donepezil—Alzheimer's disease	0.000409	0.0023	CcSEcCtD
Linezolid—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000408	0.00229	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000407	0.00508	CbGpPWpGaD
Linezolid—Convulsion—Donepezil—Alzheimer's disease	0.000406	0.00228	CcSEcCtD
Linezolid—Hypertension—Donepezil—Alzheimer's disease	0.000405	0.00227	CcSEcCtD
Linezolid—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000404	0.00227	CcSEcCtD
Linezolid—Vision blurred—Memantine—Alzheimer's disease	0.000401	0.00225	CcSEcCtD
Linezolid—Muscle spasms—Rivastigmine—Alzheimer's disease	0.0004	0.00225	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000399	0.00498	CbGpPWpGaD
Linezolid—Anaemia—Memantine—Alzheimer's disease	0.000394	0.00221	CcSEcCtD
Linezolid—Vision blurred—Rivastigmine—Alzheimer's disease	0.000393	0.0022	CcSEcCtD
Linezolid—Dry mouth—Donepezil—Alzheimer's disease	0.00039	0.00219	CcSEcCtD
Linezolid—Abdominal pain—Galantamine—Alzheimer's disease	0.00039	0.00219	CcSEcCtD
Linezolid—Body temperature increased—Galantamine—Alzheimer's disease	0.00039	0.00219	CcSEcCtD
Linezolid—Anaemia—Rivastigmine—Alzheimer's disease	0.000385	0.00216	CcSEcCtD
Linezolid—Vertigo—Memantine—Alzheimer's disease	0.000383	0.00215	CcSEcCtD
Linezolid—Leukopenia—Memantine—Alzheimer's disease	0.000381	0.00214	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000378	0.00472	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000378	0.00472	CbGpPWpGaD
Linezolid—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000375	0.0021	CcSEcCtD
Linezolid—Vertigo—Rivastigmine—Alzheimer's disease	0.000374	0.0021	CcSEcCtD
Linezolid—Cough—Memantine—Alzheimer's disease	0.000372	0.00209	CcSEcCtD
Linezolid—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00037	0.00208	CcSEcCtD
Linezolid—Convulsion—Memantine—Alzheimer's disease	0.000369	0.00207	CcSEcCtD
Linezolid—Hypertension—Memantine—Alzheimer's disease	0.000368	0.00206	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000366	0.00457	CbGpPWpGaD
Linezolid—Anorexia—Donepezil—Alzheimer's disease	0.000365	0.00205	CcSEcCtD
Linezolid—Cough—Rivastigmine—Alzheimer's disease	0.000363	0.00204	CcSEcCtD
Linezolid—Convulsion—Rivastigmine—Alzheimer's disease	0.000361	0.00203	CcSEcCtD
Linezolid—Hypertension—Rivastigmine—Alzheimer's disease	0.00036	0.00202	CcSEcCtD
Linezolid—Dry mouth—Memantine—Alzheimer's disease	0.000354	0.00199	CcSEcCtD
Linezolid—Asthenia—Galantamine—Alzheimer's disease	0.000354	0.00199	CcSEcCtD
Linezolid—Dry mouth—Rivastigmine—Alzheimer's disease	0.000347	0.00195	CcSEcCtD
Linezolid—Insomnia—Donepezil—Alzheimer's disease	0.000346	0.00194	CcSEcCtD
Linezolid—MAOB—Biological oxidations—PTGS1—Alzheimer's disease	0.000345	0.0043	CbGpPWpGaD
Linezolid—Paraesthesia—Donepezil—Alzheimer's disease	0.000344	0.00193	CcSEcCtD
Linezolid—Dyspnoea—Donepezil—Alzheimer's disease	0.000341	0.00192	CcSEcCtD
Linezolid—Somnolence—Donepezil—Alzheimer's disease	0.00034	0.00191	CcSEcCtD
Linezolid—Thrombocytopenia—Memantine—Alzheimer's disease	0.00034	0.00191	CcSEcCtD
Linezolid—MAOB—Biological oxidations—CYP2D6—Alzheimer's disease	0.000338	0.00421	CbGpPWpGaD
Linezolid—Diarrhoea—Galantamine—Alzheimer's disease	0.000338	0.0019	CcSEcCtD
Linezolid—Skin disorder—Memantine—Alzheimer's disease	0.000338	0.0019	CcSEcCtD
Linezolid—MAOA—Neuronal System—SLC18A3—Alzheimer's disease	0.000337	0.00421	CbGpPWpGaD
Linezolid—Dyspepsia—Donepezil—Alzheimer's disease	0.000337	0.00189	CcSEcCtD
Linezolid—Hyperhidrosis—Memantine—Alzheimer's disease	0.000336	0.00189	CcSEcCtD
Linezolid—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000333	0.00187	CcSEcCtD
Linezolid—Decreased appetite—Donepezil—Alzheimer's disease	0.000333	0.00187	CcSEcCtD
Linezolid—Anorexia—Memantine—Alzheimer's disease	0.000331	0.00186	CcSEcCtD
Linezolid—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00033	0.00186	CcSEcCtD
Linezolid—Skin disorder—Rivastigmine—Alzheimer's disease	0.00033	0.00185	CcSEcCtD
Linezolid—Fatigue—Donepezil—Alzheimer's disease	0.00033	0.00185	CcSEcCtD
Linezolid—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000329	0.00185	CcSEcCtD
Linezolid—Constipation—Donepezil—Alzheimer's disease	0.000327	0.00184	CcSEcCtD
Linezolid—Pain—Donepezil—Alzheimer's disease	0.000327	0.00184	CcSEcCtD
Linezolid—Dizziness—Galantamine—Alzheimer's disease	0.000327	0.00183	CcSEcCtD
Linezolid—Anorexia—Rivastigmine—Alzheimer's disease	0.000324	0.00182	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000322	0.00401	CbGpPWpGaD
Linezolid—Insomnia—Memantine—Alzheimer's disease	0.000314	0.00177	CcSEcCtD
Linezolid—Vomiting—Galantamine—Alzheimer's disease	0.000314	0.00176	CcSEcCtD
Linezolid—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000313	0.00176	CcSEcCtD
Linezolid—Paraesthesia—Memantine—Alzheimer's disease	0.000312	0.00175	CcSEcCtD
Linezolid—Rash—Galantamine—Alzheimer's disease	0.000311	0.00175	CcSEcCtD
Linezolid—Dermatitis—Galantamine—Alzheimer's disease	0.000311	0.00175	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.00031	0.00387	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.00031	0.00387	CbGpPWpGaD
Linezolid—Dyspnoea—Memantine—Alzheimer's disease	0.00031	0.00174	CcSEcCtD
Linezolid—Headache—Galantamine—Alzheimer's disease	0.000309	0.00174	CcSEcCtD
Linezolid—Somnolence—Memantine—Alzheimer's disease	0.000309	0.00174	CcSEcCtD
Linezolid—Insomnia—Rivastigmine—Alzheimer's disease	0.000307	0.00173	CcSEcCtD
Linezolid—Dyspepsia—Memantine—Alzheimer's disease	0.000306	0.00172	CcSEcCtD
Linezolid—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000305	0.00171	CcSEcCtD
Linezolid—Urticaria—Donepezil—Alzheimer's disease	0.000304	0.00171	CcSEcCtD
Linezolid—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000303	0.0017	CcSEcCtD
Linezolid—Abdominal pain—Donepezil—Alzheimer's disease	0.000303	0.0017	CcSEcCtD
Linezolid—Body temperature increased—Donepezil—Alzheimer's disease	0.000303	0.0017	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000303	0.00377	CbGpPWpGaD
Linezolid—Somnolence—Rivastigmine—Alzheimer's disease	0.000302	0.0017	CcSEcCtD
Linezolid—Decreased appetite—Memantine—Alzheimer's disease	0.000302	0.0017	CcSEcCtD
Linezolid—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.0003	0.00169	CcSEcCtD
Linezolid—Fatigue—Memantine—Alzheimer's disease	0.0003	0.00168	CcSEcCtD
Linezolid—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000299	0.00168	CcSEcCtD
Linezolid—Pain—Memantine—Alzheimer's disease	0.000297	0.00167	CcSEcCtD
Linezolid—Constipation—Memantine—Alzheimer's disease	0.000297	0.00167	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000297	0.0037	CbGpPWpGaD
Linezolid—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000295	0.00166	CcSEcCtD
Linezolid—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000293	0.00165	CcSEcCtD
Linezolid—Nausea—Galantamine—Alzheimer's disease	0.000293	0.00165	CcSEcCtD
Linezolid—Fatigue—Rivastigmine—Alzheimer's disease	0.000293	0.00165	CcSEcCtD
Linezolid—Pain—Rivastigmine—Alzheimer's disease	0.000291	0.00163	CcSEcCtD
Linezolid—Constipation—Rivastigmine—Alzheimer's disease	0.000291	0.00163	CcSEcCtD
Linezolid—MAOA—Biological oxidations—MAOB—Alzheimer's disease	0.000285	0.00356	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000284	0.0016	CcSEcCtD
Linezolid—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000278	0.00156	CcSEcCtD
Linezolid—Urticaria—Memantine—Alzheimer's disease	0.000276	0.00155	CcSEcCtD
Linezolid—Abdominal pain—Memantine—Alzheimer's disease	0.000275	0.00154	CcSEcCtD
Linezolid—Body temperature increased—Memantine—Alzheimer's disease	0.000275	0.00154	CcSEcCtD
Linezolid—Asthenia—Donepezil—Alzheimer's disease	0.000275	0.00154	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000272	0.00339	CbGpPWpGaD
Linezolid—Pruritus—Donepezil—Alzheimer's disease	0.000271	0.00152	CcSEcCtD
Linezolid—Urticaria—Rivastigmine—Alzheimer's disease	0.00027	0.00152	CcSEcCtD
Linezolid—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000269	0.00151	CcSEcCtD
Linezolid—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000269	0.00151	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000264	0.00329	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000264	0.00329	CbGpPWpGaD
Linezolid—Diarrhoea—Donepezil—Alzheimer's disease	0.000262	0.00147	CcSEcCtD
Linezolid—Dizziness—Donepezil—Alzheimer's disease	0.000253	0.00142	CcSEcCtD
Linezolid—Asthenia—Memantine—Alzheimer's disease	0.000249	0.0014	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000247	0.00308	CbGpPWpGaD
Linezolid—Pruritus—Memantine—Alzheimer's disease	0.000246	0.00138	CcSEcCtD
Linezolid—Asthenia—Rivastigmine—Alzheimer's disease	0.000244	0.00137	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000244	0.00304	CbGpPWpGaD
Linezolid—Vomiting—Donepezil—Alzheimer's disease	0.000243	0.00137	CcSEcCtD
Linezolid—Rash—Donepezil—Alzheimer's disease	0.000241	0.00136	CcSEcCtD
Linezolid—Dermatitis—Donepezil—Alzheimer's disease	0.000241	0.00135	CcSEcCtD
Linezolid—Pruritus—Rivastigmine—Alzheimer's disease	0.00024	0.00135	CcSEcCtD
Linezolid—Headache—Donepezil—Alzheimer's disease	0.00024	0.00135	CcSEcCtD
Linezolid—Diarrhoea—Memantine—Alzheimer's disease	0.000238	0.00134	CcSEcCtD
Linezolid—MAOA—Neuronal System—GRIK1—Alzheimer's disease	0.000238	0.00296	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNA7—Alzheimer's disease	0.000238	0.00296	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000235	0.00293	CbGpPWpGaD
Linezolid—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000233	0.00131	CcSEcCtD
Linezolid—Dizziness—Memantine—Alzheimer's disease	0.00023	0.00129	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000229	0.00286	CbGpPWpGaD
Linezolid—Nausea—Donepezil—Alzheimer's disease	0.000227	0.00128	CcSEcCtD
Linezolid—Dizziness—Rivastigmine—Alzheimer's disease	0.000225	0.00126	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000223	0.00278	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000223	0.00278	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000223	0.00278	CbGpPWpGaD
Linezolid—Vomiting—Memantine—Alzheimer's disease	0.000221	0.00124	CcSEcCtD
Linezolid—Rash—Memantine—Alzheimer's disease	0.000219	0.00123	CcSEcCtD
Linezolid—Dermatitis—Memantine—Alzheimer's disease	0.000219	0.00123	CcSEcCtD
Linezolid—Headache—Memantine—Alzheimer's disease	0.000218	0.00122	CcSEcCtD
Linezolid—MAOA—Biological oxidations—PTGS1—Alzheimer's disease	0.000216	0.0027	CbGpPWpGaD
Linezolid—Vomiting—Rivastigmine—Alzheimer's disease	0.000216	0.00121	CcSEcCtD
Linezolid—Rash—Rivastigmine—Alzheimer's disease	0.000214	0.0012	CcSEcCtD
Linezolid—Dermatitis—Rivastigmine—Alzheimer's disease	0.000214	0.0012	CcSEcCtD
Linezolid—Headache—Rivastigmine—Alzheimer's disease	0.000213	0.0012	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP2D6—Alzheimer's disease	0.000212	0.00264	CbGpPWpGaD
Linezolid—Nausea—Memantine—Alzheimer's disease	0.000206	0.00116	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000205	0.00255	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000202	0.00252	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIK2—Alzheimer's disease	0.000202	0.00252	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHAT—Alzheimer's disease	0.000202	0.00252	CbGpPWpGaD
Linezolid—Nausea—Rivastigmine—Alzheimer's disease	0.000202	0.00113	CcSEcCtD
Linezolid—MAOB—Metabolism—DHCR24—Alzheimer's disease	0.000195	0.00244	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIA1—Alzheimer's disease	0.00018	0.00225	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000178	0.00222	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000174	0.00217	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000171	0.00214	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNB2—Alzheimer's disease	0.000171	0.00213	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.00017	0.00212	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000168	0.0021	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000166	0.00208	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CA4—Alzheimer's disease	0.000166	0.00207	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00016	0.00199	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ACHE—Alzheimer's disease	0.000157	0.00195	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GAPDHS—Alzheimer's disease	0.000156	0.00195	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNA4—Alzheimer's disease	0.000155	0.00193	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000155	0.00193	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ATP5A1—Alzheimer's disease	0.000148	0.00185	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000148	0.00184	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLD3—Alzheimer's disease	0.000141	0.00176	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000141	0.00175	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—BCHE—Alzheimer's disease	0.000137	0.0017	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD17B10—Alzheimer's disease	0.000135	0.00169	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—DLG4—Alzheimer's disease	0.000133	0.00166	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP46A1—Alzheimer's disease	0.00013	0.00163	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIN2B—Alzheimer's disease	0.00013	0.00162	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—PLCB1—Alzheimer's disease	0.000129	0.00161	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ND1—Alzheimer's disease	0.000126	0.00157	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000124	0.00155	CbGpPWpGaD
Linezolid—MAOA—Metabolism—DHCR24—Alzheimer's disease	0.000123	0.00153	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000112	0.0014	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000108	0.00134	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CA4—Alzheimer's disease	0.000104	0.0013	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GAPDHS—Alzheimer's disease	9.8e-05	0.00122	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—PRKCG—Alzheimer's disease	9.53e-05	0.00119	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ATP5A1—Alzheimer's disease	9.29e-05	0.00116	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	9.21e-05	0.00115	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLD3—Alzheimer's disease	8.86e-05	0.0011	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD17B10—Alzheimer's disease	8.49e-05	0.00106	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	8.33e-05	0.00104	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	8.32e-05	0.00104	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CALM1—Alzheimer's disease	8.24e-05	0.00103	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP46A1—Alzheimer's disease	8.18e-05	0.00102	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CHAT—Alzheimer's disease	8.11e-05	0.00101	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TPI1—Alzheimer's disease	8.11e-05	0.00101	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ND1—Alzheimer's disease	7.9e-05	0.000985	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GAPDH—Alzheimer's disease	7.48e-05	0.000933	CbGpPWpGaD
Linezolid—MAOB—Metabolism—A2M—Alzheimer's disease	7.23e-05	0.000901	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	7.06e-05	0.00088	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CREB1—Alzheimer's disease	7.05e-05	0.00088	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ACHE—Alzheimer's disease	6.29e-05	0.000784	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INPP5D—Alzheimer's disease	6.22e-05	0.000775	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.05e-05	0.000754	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS1—Alzheimer's disease	5.89e-05	0.000735	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ENO1—Alzheimer's disease	5.89e-05	0.000735	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2D6—Alzheimer's disease	5.78e-05	0.000721	CbGpPWpGaD
Linezolid—MAOB—Metabolism—BCHE—Alzheimer's disease	5.48e-05	0.000683	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLCB1—Alzheimer's disease	5.17e-05	0.000645	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CHAT—Alzheimer's disease	5.09e-05	0.000635	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TPI1—Alzheimer's disease	5.09e-05	0.000635	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCA1—Alzheimer's disease	5.01e-05	0.000625	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.88e-05	0.000609	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MAOB—Alzheimer's disease	4.88e-05	0.000608	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GAPDH—Alzheimer's disease	4.7e-05	0.000586	CbGpPWpGaD
Linezolid—MAOA—Metabolism—A2M—Alzheimer's disease	4.54e-05	0.000566	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARGC1A—Alzheimer's disease	4.32e-05	0.000539	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMOX1—Alzheimer's disease	4.3e-05	0.000536	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ACHE—Alzheimer's disease	3.95e-05	0.000492	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPL—Alzheimer's disease	3.93e-05	0.00049	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INPP5D—Alzheimer's disease	3.9e-05	0.000486	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ENO1—Alzheimer's disease	3.7e-05	0.000461	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS1—Alzheimer's disease	3.7e-05	0.000461	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2D6—Alzheimer's disease	3.63e-05	0.000452	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTHFR—Alzheimer's disease	3.54e-05	0.000441	CbGpPWpGaD
Linezolid—MAOA—Metabolism—BCHE—Alzheimer's disease	3.44e-05	0.000429	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CALM1—Alzheimer's disease	3.31e-05	0.000412	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOE—Alzheimer's disease	3.3e-05	0.000411	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CAV1—Alzheimer's disease	3.27e-05	0.000407	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLCB1—Alzheimer's disease	3.24e-05	0.000404	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCA1—Alzheimer's disease	3.14e-05	0.000392	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARG—Alzheimer's disease	2.87e-05	0.000358	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INS—Alzheimer's disease	2.82e-05	0.000351	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	2.71e-05	0.000338	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMOX1—Alzheimer's disease	2.7e-05	0.000336	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NOS3—Alzheimer's disease	2.47e-05	0.000308	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPL—Alzheimer's disease	2.47e-05	0.000308	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—Alzheimer's disease	2.26e-05	0.000282	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTHFR—Alzheimer's disease	2.22e-05	0.000277	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CALM1—Alzheimer's disease	2.08e-05	0.000259	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOE—Alzheimer's disease	2.07e-05	0.000258	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CAV1—Alzheimer's disease	2.05e-05	0.000255	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARG—Alzheimer's disease	1.8e-05	0.000225	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INS—Alzheimer's disease	1.77e-05	0.00022	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NOS3—Alzheimer's disease	1.55e-05	0.000193	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—Alzheimer's disease	1.42e-05	0.000177	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AKT1—Alzheimer's disease	1.13e-05	0.000142	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKT1—Alzheimer's disease	7.12e-06	8.88e-05	CbGpPWpGaD
